Detalles de la búsqueda
1.
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.
Clin Infect Dis
; 75(3): 390-398, 2022 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940806
2.
Is my grief too public for you? The digitalization of grief on Facebook™.
Death Stud
; 44(2): 89-97, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-30570454
3.
Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial.
Vaccine
; 41(13): 2137-2146, 2023 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36828719
4.
Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease.
Hum Vaccin Immunother
; 18(6): 2126253, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368038
Resultados
1 -
4
de 4
1
Próxima >
>>